Senova Systems Takes Gold in Pittcon Editors’ Awards
News Apr 02, 2013
The Pittcon Editors’ Awards, started in 1996, recognize companies with the most significant and innovative new product introductions at the weeklong conference and exhibition. Editors nominate up to three new products and each nomination is subsequently presented, discussed and voted upon during a private roundtable discussion.
The pHit Scanner is the world’s first calibration-free pH meter and Senova Systems’ first product offering. Available for purchase starting this month, the pHit Scanner’s entirely new and unique technology platform incorporates an advanced sensor and electronics into a novel product design, eliminating glass electrodes and significantly enhancing usability compared to traditional pH meters. pH is one of the most widely measured properties in a diverse range of industries including pharmaceutical, medical, chemical, academic research, food and beverage and environmental testing.
The pHit Scanner is virtually maintenance-free, can be stored dry and its glass-free design eliminates the threat of broken pH electrodes. The pHit Scanner delivers significant cost savings by eliminating the time and expense associated with calibrating and maintaining delicate glass electrodes. The solid-state sensor also reduces signal drift for more accurate and reliable measurement.
“We are honored and thrilled to be the recipient of the 2013 Pittcon Editors’ Gold Award, which is a testament to the breakthrough technology of our pHit Scanner,” said Lee Leonard, CEO of Senova Systems. “Since its inception over 63 years ago, Pittcon has been one of the most important international conferences for laboratory science. We were gratified by the accolades we received from the press, as well as by the hundreds of inquiries from prospective customers. The pHit Scanner clearly represents the future in pH measurement.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Simple Sugar Prevents Neurodegeneration in Lysosomal Storage DiseaseNews
New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)READ MORE